Anticonvulsant effect of retigabine during postnatal development in rats

Epilepsy Research

Volumn 101, Issue 1-2, 2012, Pages 135-140

  Forcelli, Patrick A ^a   Soper, Colin ^a   Lakhkar, Anand ^a   Gale, Karen ^a   Kondratyev, Alexei ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiepileptic drug; Development; Ezogabine; Neonatal; Pentylenetetrazol; Retigabine; Seizure

Indexed keywords

PENTETRAZOLE; POTASSIUM CHANNEL KCNQ; RETIGABINE;

ADOLESCENCE; AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN DEVELOPMENT; CHILDHOOD; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; FEMALE; NEWBORN PERIOD; NONHUMAN; POSTNATAL DEVELOPMENT; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT; SEIZURE;

AGING; ANIMALS; ANIMALS, NEWBORN; ANTICONVULSANTS; CARBAMATES; CONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; FEMALE; INJECTIONS, SUBCUTANEOUS; KINDLING, NEUROLOGIC; PENTYLENETETRAZOLE; PHENYLENEDIAMINES; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 84865100352     PISSN: 09201211     EISSN: 18726844     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2012.03.006     Document Type: Article

References (23)

1. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 1998, 279:403-406.
2. Bittigau P., Sifringer M., Genz K., Reith E., Pospischil D., Govindarajalu S., Dzietko M., Pesditschek S., Mai I., Dikranian K., Olney J.W., Ikonomidou C. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:15089-15094.
3. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 1998, 18:53-55.
4. Food and Drug Administration Potiga Approval History 2011.
5. Forcelli P., Kim J., Kondratyev A., Gale K. Pattern of antiepileptic drug induced cell death in limbic regions of the neonatal rat brain. Epilepsia 2011, 52:e207-e211.
6. Geiger J., Weber Y.G., Landwehrmeyer B., Sommer C., Lerche H. Immunohistochemical analysis of KCNQ3 potassium channels in mouse brain. Neurosci. Lett. 2006, 400:101-104.
7. Kim J., Gale K., Kondratyev A. Effects of repeated minimal electroshock seizures on NGF. BDNF and FGF-2 protein in the rat brain during postnatal development. Int. J. Dev. Neurosci. 2010, 28:227-232.
8. Kirkman T.W. Statistics to Use 1996, http://www.physics.csbsju.edu/stats/ (February 2012).
9. Kubova H., Mares P. Anticonvulsant effects of phenobarbital and primidone during ontogenesis in rats. Epilepsy Res. 1991, 10:148-155.
10. Kubová H., Mares P. Anticonvulsant action of oxcarbazepine, hydroxycarbamazepine, and carbamazepine against metrazol-induced motor seizures in developing rats. Epilepsia 1993, 34:188-192.
11. Main M.J., Cryan J.E., Dupere J.R., Cox B., Clare J.J., Burbidge S.A. Modulation of KCNQ2/3 potassium channels by the novel anticonvulsant retigabine. Mol. Pharmacol. 2000, 58:253-262.
12. Mares P., Maresová S., Maresová D. Antimetrazol action and plasma levels of valproate in developing rats. Physiol. Bohemoslov. 1989, 38:97-107.
13. Mazarati A., Wu J., Shin D., Kwon Y.S., Sankar R. Antiepileptogenic and antiictogenic effects of retigabine under conditions of rapid kindling: an ontogenic study. Epilepsia 2008, 49:1777-1786.
14. Rostock A., Tober C., Rundfeldt C., Bartsch R., Engel J., Polymeropoulos E.E., Kutscher B., Löscher W., Hönack D., White H.S., Wolf H.H. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res. 1996, 23:211-223.
15. + channels in neuronal cells. Eur. J. Pharmacol. 1997, 336:243-249.
16. Rundfeldt C., Netzer R. The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells transfected with human KCNQ2/3 subunits. Neurosci. Lett. 2000, 282:73-76.
17. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E., Leppert M. A novel potassium channel gene. KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 1998, 18:25-29.
18. Stanková L., Kubová H., Mares P. Anticonvulsant action of lamotrigine during ontogenesis in rats. Epilepsy Res. 1992, 13:17-22.
19. Tatulian L., Delmas P., Abogadie F.C., Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 2001, 21:5535-5545.
20. Tinel N., Lauritzen I., Chouabe C., Lazdunski M., Borsotto M. The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3. FEBS Lett. 1998, 438:171-176.
21. Tober C., Rostock A., Rundfeldt C., Bartsch R. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. Eur. J. Pharmacol. 1996, 303:163-169.
22. Weber Y.G., Geiger J., Kämpchen K., Landwehrmeyer B., Sommer C., Lerche H. Immunohistochemical analysis of KCNQ2 potassium channels in adult and developing mouse brain. Brain Res. 2006, 1077:1-6.
23. Wickenden A.D., Yu W., Zou A., Jegla T., Wagoner P.K. Retigabine, a novel anti-convulsant, enhances activation of KCNQ2/Q3 potassium channels. Mol. Pharmacol. 2000, 58:591-600.